Clinical Trials Business Science

Recent News

View All

Thursday, February 4, 2010
EntreMed Raises Additional $2.5 Million in Registered Direct Offering
Wednesday, January 20, 2010
EntreMed Receives NASDAQ Staff Determination Letter Regarding Non-Compliance with Minimum Bid Price Rule and Requests Hearing
Tuesday, January 12, 2010
EntreMed Completes Registered Direct Offering of $2.5 Million in Common Stock
Friday, December 11, 2009
EntreMed Reports Receipt of Third Quarter Royalty Payment
Monday, November 16, 2009
EntreMed’s ENMD-2076 Active in Solid and Hematological Cancers

Stay Informed

Enter your e-mail address to receive press releases electronically. (Manage your subscription)